AbbVie Inc. (ABBV) Overview
Healthcare • NYSE • CIK 0001551152
Loading...
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Market Cap
$520.54B
P/E (TTM)
50.6x
Rev Growth (TTM)
+10.7%
Net Margin (TTM)
15.7%
FCF Yield (TTM)
3.6%
FCF Margin (TTM)
28.6%
Figures as of September 30, 2026
Filings
Primary-source SEC disclosures, read end-to-end. SEC figures cite the filing they come from.
10-Q2026 Q32026-11-03source
8-KNov 20262026-11-02source
8-KEarnings2026-10-30source
8-KOct 20262026-10-15source
8-KEarnings2026-10-05source
What your agent reads
Investor Relations
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
Company-published, not SEC-audited
Earnings
Q3
17 days ago
8-K releaseRevenue
$17.40B
+10.3%
Net Income
$4.22B
—
EPS
N/A
—
Earnings call — not catalogued
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow8/8 positive
TTM$18.9B
Q3 '26
$7.3B+135%
Q2 '26
$3.1B-13%
FCF Margin
TTM28.6%
Q3 '2642.0%+129%
Sector: 3.0%Top 25%
OCF Margin
30.4%
OCF/NI1.94x
CapEx Coverage
16.5x
FCF Yield3.6%
FCF Growth (3Y)-9%
Cash Conversion Cycle
–
DSO: 72+DIO: 107−DPO: –
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder YieldTTM
TTM2.6%
Div Yield2.3%
+Buyback (TTM)0.3%
Dividend & Payout Metrics
Dividend Yield (TTM)2.3%
FCF Payout Ratio64.8%
Free Cash Flow (TTM)$18.9B
Stock Repurchases (TTM)$1.5B
Capital Return / FCF72.3%
Shares Outstanding (YoY)0.0%
Est. Dividends Paid (TTM)$12.2B
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
50.6x
Volatile
8Q: 64.2x
Valuation Lenses
Earnings
50.6x
vs – sector
Cash Flow
31.3x
EV/FCF vs –
Growth-Adj
0.1xPEG
Undervalued for growth
Quality-Adj
2.5P/E per %ROIC
ROIC: 20.4%
Shareholder Returns
Dividend
2.3%
Buyback
0.3%
Total Yield
2.6%
Market Cap$520.54B
EV$590.67B
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 75th pctile
Profitability Cascade
Gross
73.7%
Operating
32.2%
Top 25% in sector
Net
15.7%
Margins Unknown
Return on Invested CapitalTTM
20.4%
Moderate
+0.1% YoY8Q: 13.2%+22.8%
P25MedianP75
75th pctl (med: -6.9%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
26.0%
8Q: 18.9%
Asset Turnover
0.48x
8Q: 0.46x
Leverage (1+D/E)
–
Asset & CapEx Efficiency
Fixed Asset Turn
11.57x
8Q:11.74x
+44.4%
Invested Cap Turn
0.79x
8Q:0.73x
+17.2%
CapEx Intensity
1.4%
8Q:1.3%
CapEx/Depreciation
0.16x
FCF vs Net Margin Gap+12.9 pts
Depreciation Rate Trend
⚠ Declining -15.8%
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
ND/EBITDA 2.2x
Net Debt / EBITDA
2.2xNet Debt: $70.13B
Interest Coverage
7.1x
+Strong interest coverage: 7.1x
Leverage Metrics
Debt-to-Equity
–
Balance sheet risk & solvency analysis
Related Research
3 related posts